WallStreetZenWallStreetZen

NASDAQ: LSTA
Lisata Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for LSTA

Based on 1 analyst offering 12 month price targets for Lisata Therapeutics Inc.
Min Forecast
$15.00+455.56%
Avg Forecast
$15.00+455.56%
Max Forecast
$15.00+455.56%

Should I buy or sell LSTA stock?

Based on 1 analyst offering ratings for Lisata Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LSTA stock forecasts and price targets.

LSTA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-01

1 of 1

Forecast return on equity

Is LSTA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
36%

Forecast return on assets

Is LSTA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

LSTA revenue forecast

What is LSTA's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$7.2M

LSTA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LSTA$2.70$15.00+455.56%Buy
CERO$1.50N/AN/A
NRSN$1.42N/AN/A
SYBX$1.87$15.50+728.88%Buy
AIM$0.47N/AN/A
View Top Biotech Stocks

Lisata Therapeutics Stock Forecast FAQ

Is Lisata Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: LSTA) stock is to Buy LSTA stock.

Out of 1 analyst, 0 (0%) are recommending LSTA as a Strong Buy, 1 (100%) are recommending LSTA as a Buy, 0 (0%) are recommending LSTA as a Hold, 0 (0%) are recommending LSTA as a Sell, and 0 (0%) are recommending LSTA as a Strong Sell.

If you're new to stock investing, here's how to buy Lisata Therapeutics stock.

What is LSTA's revenue growth forecast for 2028-2028?

(NASDAQ: LSTA) Lisata Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.06%.

Lisata Therapeutics's revenue in 2024 is $0.

In 2028, LSTA is forecast to generate $59,813,518 in revenue, with the lowest revenue forecast at $59,813,518 and the highest revenue forecast at $59,813,518.

What is LSTA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: LSTA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is LSTA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year LSTA price target, the average LSTA price target is $15.00, with the highest LSTA stock price forecast at $15.00 and the lowest LSTA stock price forecast at $15.00.

The Wall Street analyst predicted that Lisata Therapeutics's share price could reach $15.00 by Mar 1, 2025. The average Lisata Therapeutics stock price prediction forecasts a potential upside of 455.56% from the current LSTA share price of $2.70.

What is LSTA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: LSTA) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.